House E&C Offers Recommendations to Improve 340B Drug Pricing Program
By Zachary Brennan -
Published 10 January 2018
The House Energy & Commerce (E&C) Committee on Wednesday released an 80-page report outlining issues related to the 340B drug pricing program, which helps reduce the prices of certain drugs for participating hospitals, health centers and other entities that provide care for vulnerable patients, and recommendations to improve the program’s administration.
Categories: News, US, Drugs, Government affairs, Reimbursement
Tags: HRSA, 340B, drug discount, House Energy & Commerce